Doxapram and developmental delay at 12 months in children born extremely preterm

Ane Lando; Anja Klamer; Finn Jonsbo; Janne Weiss; Gorm Greisen

doi:10.1080/08035250500254449

Doxapram and developmental delay at 12 months in children born extremely preterm

Ane Lando, Anja Klamer, Finn Jonsbo, Janne Weiss, Gorm Greisen

Neonatology, Department of

10 Citations (Scopus)

Abstract

AIM: To examine the relation of doxapram to a developmental score achieved by a structured telephone interview in a group of extremely-preterm-born children.

METHODS: Parents of 88 children born extremely preterm were contacted by telephone and interviewed by a structured questionnaire (R-PDQ) when the corrected age of their child was 9-15 mo.

RESULTS: We found that doxapram treatment was associated with a deficit in age-adjusted R-PDQ score.

CONCLUSION: Doxapram may have a negative effect on neurodevelopmental outcome.

Original language	English
Journal	Acta paediatrica
Volume	94
Issue number	11
Pages (from-to)	1680-1
Number of pages	2
ISSN	0803-5253
DOIs	https://doi.org/10.1080/08035250500254449
Publication status	Published - Nov 2005

Keywords

Case-Control Studies
Developmental Disabilities
Doxapram
Female
Humans
Infant, Newborn
Infant, Premature
Infant, Very Low Birth Weight
Linear Models
Male
Respiratory System Agents

Access to Document

10.1080/08035250500254449

Cite this

@article{b7c6b62af0c647b1bed2a0f686900135,

title = "Doxapram and developmental delay at 12 months in children born extremely preterm",

abstract = "AIM: To examine the relation of doxapram to a developmental score achieved by a structured telephone interview in a group of extremely-preterm-born children.METHODS: Parents of 88 children born extremely preterm were contacted by telephone and interviewed by a structured questionnaire (R-PDQ) when the corrected age of their child was 9-15 mo.RESULTS: We found that doxapram treatment was associated with a deficit in age-adjusted R-PDQ score.CONCLUSION: Doxapram may have a negative effect on neurodevelopmental outcome.",

keywords = "Case-Control Studies, Developmental Disabilities, Doxapram, Female, Humans, Infant, Newborn, Infant, Premature, Infant, Very Low Birth Weight, Linear Models, Male, Respiratory System Agents",

author = "Ane Lando and Anja Klamer and Finn Jonsbo and Janne Weiss and Gorm Greisen",

year = "2005",

month = nov,

doi = "10.1080/08035250500254449",

language = "English",

volume = "94",

pages = "1680--1",

journal = "Acta paediatrica",

issn = "1651-2227",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "11",

}

TY - JOUR

T1 - Doxapram and developmental delay at 12 months in children born extremely preterm

AU - Lando, Ane

AU - Klamer, Anja

AU - Jonsbo, Finn

AU - Weiss, Janne

AU - Greisen, Gorm

PY - 2005/11

Y1 - 2005/11

N2 - AIM: To examine the relation of doxapram to a developmental score achieved by a structured telephone interview in a group of extremely-preterm-born children.METHODS: Parents of 88 children born extremely preterm were contacted by telephone and interviewed by a structured questionnaire (R-PDQ) when the corrected age of their child was 9-15 mo.RESULTS: We found that doxapram treatment was associated with a deficit in age-adjusted R-PDQ score.CONCLUSION: Doxapram may have a negative effect on neurodevelopmental outcome.

AB - AIM: To examine the relation of doxapram to a developmental score achieved by a structured telephone interview in a group of extremely-preterm-born children.METHODS: Parents of 88 children born extremely preterm were contacted by telephone and interviewed by a structured questionnaire (R-PDQ) when the corrected age of their child was 9-15 mo.RESULTS: We found that doxapram treatment was associated with a deficit in age-adjusted R-PDQ score.CONCLUSION: Doxapram may have a negative effect on neurodevelopmental outcome.

KW - Case-Control Studies

KW - Developmental Disabilities

KW - Doxapram

KW - Female

KW - Humans

KW - Infant, Newborn

KW - Infant, Premature

KW - Infant, Very Low Birth Weight

KW - Linear Models

KW - Male

KW - Respiratory System Agents

U2 - 10.1080/08035250500254449

DO - 10.1080/08035250500254449

M3 - Journal article

C2 - 16303710

VL - 94

SP - 1680

EP - 1681

JO - Acta paediatrica

JF - Acta paediatrica

SN - 1651-2227

IS - 11

ER -

Doxapram and developmental delay at 12 months in children born extremely preterm

Abstract

Keywords

Access to Document

Fingerprint

Cite this